STOCK TITAN

Clover Health officer proposes $110K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Clover Health Investments, Corp. (CLOV) officer Joseph Clay Thornton filed notice of a proposed sale of 22,099 Class A common shares, with an aggregate market value of $109,831.46 and an approximate sale date of November 16, 2026. The notice says the proposed sale would cover tax withholding obligations connected with restricted stock unit vesting and settlement through a “sell to cover” transaction, and is not discretionary. It lists March 2, 2026, as the plan adoption or instruction date if relying on Rule 10b5-1. During the prior three months, Thornton reported sales of 17,775 shares for gross proceeds of $78,032.25 on August 17, 2026, and 4,591 shares for gross proceeds of $21,485.88 on October 15, 2026.

Proposed sale shares 22,099 Class A common shares Approximate sale date: November 16, 2026.
Proposed sale aggregate market value $109,831.46 For the proposed sale of 22,099 Class A common shares.
Approximate sale date November 16, 2026 Date reported for the proposed sale.
Class A common shares outstanding 439,707,261 shares Number reported in the securities information.
Prior sale shares 17,775 shares Sale dated August 17, 2026.
Prior sale gross proceeds $78,032.25 Proceeds reported for the August 17, 2026 sale.
Prior sale shares 4,591 shares Sale dated October 15, 2026.
Prior sale gross proceeds $21,485.88 Proceeds reported for the October 15, 2026 sale.
Restricted Stock Units financial
"Nature of Acquisition Transaction: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"funded by a “sell to cover” transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLOV shares did Joseph Clay Thornton propose to sell?

The notice identifies a proposed sale of 22,099 Class A common shares, an aggregate market value of $109,831.46, and an approximate sale date of November 16, 2026.

Why is Joseph Clay Thornton proposing to sell CLOV shares?

The notice says the proposed sale is intended to fund tax withholding obligations tied to restricted stock unit vesting and settlement through a “sell to cover” transaction; it says the sales are not discretionary transactions by Thornton.

What CLOV sales did Joseph Clay Thornton report in the prior three months?

Thornton reported sales of 17,775 shares for gross proceeds of $78,032.25 on August 17, 2026, and 4,591 shares for gross proceeds of $21,485.88 on October 15, 2026.

What Rule 10b5-1 date does CLOV’s notice list?

The notice lists March 2, 2026, as the date of plan adoption or giving of instruction if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading